Medical Developments International Limited
(ASX:MVP) has signed deals in the US and Portugal for the distribution, sales and marketing of its respiratory devices.
AmerisourceBergen will distribute Medical Developments’ range of Anti-static Compact Space Chamber respiratory devices in the US.
Medical Developments’ CEO, John Sharman, says that there is significant interest in his company’s range of respiratory products and that the first shipment will arrive in the US this week.
In Portgual, OverPharama will have exclusive sales and marketing rights over Medical Developments’ respiratory devices.
Medical Developments International reported a net profit of $236,000 at 31 December 2015.
